New patent for Amgen Inc drug LUMAKRAS

Annual Drug Patent Expirations for LUMAKRAS Lumakras is a drug marketed by Amgen Inc and is included in one NDA. It is available from one supplier. There are two patents…
The post New patent for Amgen Inc drug LUMAKRAS appeared first on DrugPatentWatch…


Pharmaceutical companies with the most orphan drugs

Orphan drug exclusivity is granted to drugs addressing rare ‘orphan diseases’ — those affecting fewer than 200,000 Americans. The protection granted to orphan drugs is quite strong. The FDA is…
The post Pharmaceutical companies with the most orphan dru…


Get email updates

Get new actionable insights and updates from BiotechBlog

Biotechblog